Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24401662 | 0.97 | KDM4E (0.37) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL24401415 | 0.88 | MAPT (0.34) | KDM4EL3MBTL1ALDH1A1MAPTTDP1 | |
| SCHEMBL24401409 | 0.85 | KDM4E (0.38) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL24401430 | 0.85 | KDM4E (0.38) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL17380959 | 0.84 | KDM4E (0.53) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL20129527 | 0.84 | KDM4E (0.53) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL23058894 | 0.84 | KDM4E (0.53) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL14681689 | 0.83 | KDM4E (0.46) | KDM4EL3MBTL1ATMALDH1A1POLB | |
| SCHEMBL20199493 | 0.83 | KDM4E (0.51) | KDM4EL3MBTL1ATMALDH1A1MAPT | |
| SCHEMBL14681702 | 0.82 | KDM4E (0.47) | KDM4EL3MBTL1ATMALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220140249-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220140249-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE | CDYL, MRPL38, CDYL2 | KDM4E 3526/4885L3MBTL1 267/4885ATM 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.